title: Incidence of infusion-related reaction to monoclonal antibody rituximab: a national kidney and transplant institute experience.
authors.forename: Jose Enrique
authors.initials: JE
authors.lastname: Montoya
authors.forename: Herdee Gloriane
authors.initials: HG
authors.lastname: Luna
authors.forename: Nunilon G
authors.initials: NG
authors.lastname: Vergara
authors.forename: Jose Roberto
authors.initials: JR
authors.lastname: Amparo
authors.forename: Gloria R
authors.initials: GR
authors.lastname: Cristal-Luna
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D015994:Incidence; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011292:Premedication / Q000009:adverse effects*; D011899:Ranitidine / Q000009:adverse effects*; D012189:Retrospective Studies; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D011899:Ranitidine